InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
40%
T+90 mean return
-0.1%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by SBLENDORIO GLENN, Director. Insider active across 4 companies, notably Intercept Pharmaceuticals, INC.. In total, 36 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €2m. History available since 27 May 2021. The latest transaction was filed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations36 total
11,847 shares0Common StockSEC:0000950170-24-071004:0
15,000 shares@ US$2.8025.7% of flowCommon StockSEC:0000950170-24-029458:0
23,447 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117109:0
239,275 sharesCommon StockSEC:0001104659-23-080686:0
11,084 shares@ US$13.2165.9% of flowCommon StockSEC:0001410939-23-000099:0
8,584 shares0Common StockSEC:0001209191-23-036418:0
8,111 shares0Common StockSEC:0001104659-23-064845:0
15,000 shares@ US$3.3230.9% of flowCommon StockSEC:0001209191-23-031103:0
31,500 shares0Common StockSEC:0001410939-23-000008:0
30,000 shares0Common StockSEC:0001410939-22-000152:0
36,658 shares0Common StockSEC:0001410939-22-000138:0
23,750 shares0Common StockSEC:0001410939-22-000126:0
50,000 shares@ US$23.0151.2% of flowCommon StockSEC:0001410939-22-000110:0
12,671 shares0Common StockSEC:0001209191-22-035852:0
7,737 shares0Common StockSEC:0001104659-22-065913:0
50,000 shares@ US$18.756187.7% of flowCommon StockSEC:0001410939-22-000048:0
1,213 shares@ US$2.940.3% of flowCommon StockSEC:0001410939-22-000040:0
18,775 shares@ US$2.945.1% of flowCommon StockSEC:0001410939-22-000031:0
3,479 shares@ US$2.940.9% of flowCommon StockSEC:0001410939-22-000023:0
15,000 shares@ US$4.790.0014% mcap100.0% of flowCommon StockSEC:0001209191-22-016793:0
100 shares@ US$2.940.0% of flowCommon StockSEC:0001104659-22-000502
100 shares@ US$2.940.0% of flowCommon StockSEC:0001104659-22-000502:0
22,163 shares@ US$1.451.3% of flowCommon StockSEC:0001104659-21-153685
22,163 shares@ US$1.452.9% of flowCommon StockSEC:0001104659-21-153685:0
36,658 sharesCommon StockSEC:0001104659-21-152293
25 of 36 declarations
About SBLENDORIO GLENN
Glenn Sblendorio is an executive at Intercept Pharmaceuticals, Inc.
